Page last updated: 2024-08-17

D-arabinopyranose and Diabetes Mellitus, Type 2

D-arabinopyranose has been researched along with Diabetes Mellitus, Type 2 in 1 studies

*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alpert, E; Ben Yakir, M; Cerasi, E; Cohen, G; Elgart, A; Gruzman, A; Hoffman, A; Katzhendler, Y; Sandovski, D; Sasson, S; Shamni, O1

Other Studies

1 other study(ies) available for D-arabinopyranose and Diabetes Mellitus, Type 2

ArticleYear
Novel D-xylose derivatives stimulate muscle glucose uptake by activating AMP-activated protein kinase alpha.
    Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24

    Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Drug Design; Enzyme Activation; Glucose; Glucose Transporter Type 4; Humans; Models, Biological; Models, Chemical; Muscles; Rats; Structure-Activity Relationship; Xylose

2008